110 related articles for article (PubMed ID: 30241382)
1. ZKSCAN3 Upregulation and Its Poor Clinical Outcome in Uterine Cervical Cancer.
Lee S; Cho YE; Kim JY; Park JH
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30241382
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis.
Zhang X; Wang CX; Zhu CB; Zhang J; Kan SF; Du LT; Li W; Wang LL; Wang S
Int J Gynecol Cancer; 2010 Dec; 20(9):1597-603. PubMed ID: 21370603
[TBL] [Abstract][Full Text] [Related]
3. ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion.
Kawahara T; Inoue S; Ide H; Kashiwagi E; Ohtake S; Mizushima T; Li P; Li Y; Zheng Y; Uemura H; Netto GJ; Ishiguro H; Miyamoto H
Oncotarget; 2016 Aug; 7(33):53599-53610. PubMed ID: 27447553
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of ZKSCAN3 (ZNF306) Expression in Gastric Carcinoma.
Takano Y; Shida A; Fujisaki M; Mitsumori N; Yanaga K
Anticancer Res; 2020 Jan; 40(1):81-86. PubMed ID: 31892555
[TBL] [Abstract][Full Text] [Related]
5. Expression of ZKSCAN3 protein suppresses proliferation, migration, and invasion of pancreatic cancer through autophagy.
Nonoyama K; Matsuo Y; Sugita S; Eguchi Y; Denda Y; Murase H; Kato T; Imafuji H; Saito K; Morimoto M; Ogawa R; Takahashi H; Mitsui A; Kimura M; Takiguchi S
Cancer Sci; 2024 Jun; 115(6):1964-1978. PubMed ID: 38671550
[TBL] [Abstract][Full Text] [Related]
6. The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migration.
Zhang X; Jing Y; Qin Y; Hunsucker S; Meng H; Sui J; Jiang Y; Gao L; An G; Yang N; Orlowski RZ; Yang L
Int J Biochem Cell Biol; 2012 Jul; 44(7):1166-73. PubMed ID: 22531714
[TBL] [Abstract][Full Text] [Related]
7. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
Jin X; Jiao X; Jiao J; Zhang T; Cui B
Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
[TBL] [Abstract][Full Text] [Related]
9. ZKSCAN3 promotes breast cancer cell proliferation, migration and invasion.
Chi Y; Xu H; Wang F; Chen X; Shan Z; Sun Y; Fan Q
Biochem Biophys Res Commun; 2018 Sep; 503(4):2583-2589. PubMed ID: 30049438
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN.
Yang YK; Xi WY; Xi RX; Li JY; Li Q; Gao YE
Oncol Rep; 2015 May; 33(5):2393-401. PubMed ID: 25738254
[TBL] [Abstract][Full Text] [Related]
11. ZKSCAN3 Facilitates Liver Metastasis of Colorectal Cancer Associated with CEA-expressing Tumor.
Kim CW; Roh SA; Tak KH; Koh BM; Ha YJ; Cho DH; Kim SY; Kim YS; Kim JC
Anticancer Res; 2016 May; 36(5):2397-406. PubMed ID: 27127149
[TBL] [Abstract][Full Text] [Related]
12. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma.
Yang L; Wang H; Kornblau SM; Graber DA; Zhang N; Matthews JA; Wang M; Weber DM; Thomas SK; Shah JJ; Zhang L; Lu G; Zhao M; Muddasani R; Yoo SY; Baggerly KA; Orlowski RZ
Oncogene; 2011 Mar; 30(11):1329-40. PubMed ID: 21057542
[TBL] [Abstract][Full Text] [Related]
14. A clinical, biologic and mechanistic analysis of the role of ZNF692 in cervical cancer.
Zhu B; Pan Y; Zheng X; Zhang Q; Wu Y; Luo J; Li Q; Lu E; Xu L; Jin G; Ren B
Gynecol Oncol; 2019 Feb; 152(2):396-407. PubMed ID: 30466806
[TBL] [Abstract][Full Text] [Related]
15. Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation.
Dong P; Xiong Y; Hanley SJB; Yue J; Watari H
J Exp Clin Cancer Res; 2017 Oct; 36(1):150. PubMed ID: 29073938
[TBL] [Abstract][Full Text] [Related]
16. Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer.
Zhou X; Xu CJ; Wang JX; Dai T; Ye YP; Cui YM; Liao WT; Wu XL; Ou JP
Int J Gynecol Cancer; 2015 Oct; 25(8):1353-63. PubMed ID: 26332389
[TBL] [Abstract][Full Text] [Related]
17. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
18. [Expression of SNAIL mRNA in uterine cervical cancer is detected by real-time PCR].
Zhao L; Chen W; Li X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):414-7. PubMed ID: 18575328
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
